tiprankstipranks

L. Becker Hewes Insider Profile

4 Followers
L. Becker Hewes, Chief Medical Officer at Damora Therapeutics, holds 264.63K shares in Damora Therapeutics (Ticker: DMRA), holds 0.00 shares in Blueprint Medicines (Ticker: BPMC).
tipranks
L. Becker Hewes

L. Becker Hewes
Damora Therapeutics (DMRA)
Chief Medical Officer

Ranked #85,861 out of 109,030 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

-18.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
100.00%
A breakdown of L. Becker Hewes's holdings

Insider Roles

Damora Therapeutics
(DMRA)
Chief Medical Officer
Roles that L. Becker Hewes holds in companies

Most Profitable Insider Trade

Stock:
Blueprint Medicines
(BPMC)
Rating:Informative Sell
Date:Sep 17, 2021 - Sep 17, 2022
Return:+34.60%
The most profitable trade made by L. Becker Hewes

L. Becker Hewes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Damora Therapeutics
Jan 07, 2026
Chief Medical Officer
Uninformative Buy
$7.44M
BPMC
Blueprint Medicines
Jul 21, 2025
Uninformative Buy
$0.00
List of latest transactions for each holding click on a transaction to see L. Becker Hewes's performance on stock

L. Becker Hewes insider profile FAQ

What is the percentage of profitable transactions made by L. Becker Hewes?
The percentage of profitable transactions made by L. Becker Hewes is 67%.
    What is the average return per transaction made by L. Becker Hewes?
    The average return per transaction made by L. Becker Hewes is -18.70%.
      What stocks does L. Becker Hewes hold?
      L. Becker Hewes holds: DMRA, BPMC stocks.
        What was L. Becker Hewes’s latest transaction?
        L. Becker Hewes latest transaction was an Uninformative Buy of ―.
          What was L. Becker Hewes's most profitable transaction?
          L. Becker Hewes’s most profitable transaction was an Informative Sell of BPMC stock on September 17, 2021. The return on the trade was 34.60%.
            What is L. Becker Hewes's role in Damora Therapeutics?
            L. Becker Hewes's role in Damora Therapeutics is Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.